AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. After more than a decade of leading pharmaceutical ...

AbbVie announced longtime CEO Richard Gonzalez will step down and be succeeded by president and chief operating officer Robert Michael. The pharma giant announced Tuesday morning that Gonzalez will ...

AbbVie Inc.’s Chief Executive Officer Richard A. Gonzalez will retire after a colorful tenure that included the multibillion takeover of Botox-maker Allergan as he raced to wean the company off ...

Gifting allows recipients to access the article for free. In his last full year as AbbVie CEO, Richard Gonzalez saw his 2023 paycheck shrink slightly amid declining revenues as the pharmaceutical ...

Feb 20 (Reuters) - AbbVie (ABBV.N), opens new tab on Tuesday said Chief Operating Officer Robert Michael would succeed Richard Gonzalez to become the second-ever CEO of the drugmaker on July 1.

AbbVie CEO Richard Gonzalez, the only chief executive in the big drugmaker’s history, will retire on July 1, the company said Tuesday. Gonzalez will be succeeded by current company president and ...

AbbVie Inc.’s founding CEO Richard Gonzalez will step down July 1, the drugmaker said Tuesday, and will be replaced by the company’s current president and chief operating officer, Robert Michael.

AbbVie's CEO Richard Gonzalez wanted one thing and one thing only for Christmas: Cerevel Therapeutics wrapped up quickly and neatly under his Christmas tree. After months of negotiations ...

The speculation over who will replace long-serving AbbVie chief executive Richard Gonzalez is over, as the company confirms that president and chief operating officer Robert Michael will take the ...

AbbVie’s other top execs cashed in last year, as well. Incoming CEO Michael saw his total compensation increase from $9.8 million to $14.4 million, with most of the bump coming from his change ...

Former AbbVie CEO Richard Gonzalez sold his Hidden Hills home for $21.7 million in the pharma executive’s latest real estate move this year. The closing had been expected after the six-bed ...